Meyka Pro banner
NIHON CHOUZAI Co.,Ltd.

NIHON CHOUZAI Co.,Ltd. Fundamental Analysis (JPX: 3341.T)

3341.TJPX
HealthcareMedical - Pharmaceuticals
¥3910.00
¥15.00(0.38%)
Japanese Market opens in 17h 10m

NIHON CHOUZAI Co.,Ltd. Fundamental Analysis (JPX: 3341.T)

NIHON CHOUZAI Co.,Ltd. (JPX: 3341.T) shows weak financial fundamentals with a PE ratio of 62.10, profit margin of 0.67%, and ROE of 3.16%. The company generates $282.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position14.12%
PEG Ratio-0.09

Areas of Concern

ROE3.16%
Operating Margin2.37%
We analyze 3341.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 26.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
26.0/100

We analyze 3341.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

3341.T struggles to generate sufficient returns from assets.

ROA > 10%
0.89%

Valuation Score

Moderate

3341.T shows balanced valuation metrics.

PE < 25
62.10
PEG Ratio < 2
-0.09

Growth Score

Moderate

3341.T shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

3341.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.95
Current Ratio > 1
1.33

Profitability Score

Weak

3341.T struggles to sustain strong margins.

ROE > 15%
3.16%
Net Margin ≥ 15%
0.67%
Positive Free Cash Flow
No

Key Financial Metrics

Is 3341.T Expensive or Cheap?

P/E Ratio

3341.T trades at 62.10 times earnings. This suggests a premium valuation.

62.10

PEG Ratio

When adjusting for growth, 3341.T's PEG of -0.09 indicates potential undervaluation.

-0.09

Price to Book

The market values NIHON CHOUZAI Co.,Ltd. at 1.95 times its book value. This may indicate undervaluation.

1.95

EV/EBITDA

Enterprise value stands at 7.35 times EBITDA. This is generally considered low.

7.35

How Well Does 3341.T Make Money?

Net Profit Margin

For every $100 in sales, NIHON CHOUZAI Co.,Ltd. keeps $0.67 as profit after all expenses.

0.67%

Operating Margin

Core operations generate 2.37 in profit for every $100 in revenue, before interest and taxes.

2.37%

ROE

Management delivers $3.16 in profit for every $100 of shareholder equity.

3.16%

ROA

NIHON CHOUZAI Co.,Ltd. generates $0.89 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.89%

Following the Money - Real Cash Generation

Operating Cash Flow

NIHON CHOUZAI Co.,Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

NIHON CHOUZAI Co.,Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

3341.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

62.10

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.09

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.95

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.41

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.95

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.33

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.009

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How 3341.T Stacks Against Its Sector Peers

Metric3341.T ValueSector AveragePerformance
P/E Ratio62.1031.61 Worse (Expensive)
ROE3.16%541.00% Weak
Net Margin0.67%30180.00% Weak
Debt/Equity0.950.54 Weak (High Leverage)
Current Ratio1.335.70 Neutral
ROA0.89%-8.00% (disorted) Weak

3341.T outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews NIHON CHOUZAI Co.,Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ